Back to ALCView Full LandscapeView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
3 competitors in Open-angle Glaucoma
ALCOX.PANCX 470 0.1%
Phase 3ALCOX.PANCX 470 0.065% (initial phase of trial)
Phase 3ABBVBimatoprost (SR)
Phase 3Drug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspensionPhase 3
Open-Angle Glaucoma
AL-4943A Ophthalmic Solution VehiclePhase 3
Allergic Conjunctivitis
RimexolonePhase 3
Dry Eye
Latanoprost 0.005% Ophthalmic Solution (XALATAN)Phase 3
Open-Angle Glaucoma
Nepafenac Ophthalmic Suspension, 0.1%Phase 3
Cataract
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts